Discover trends, market shifts, and competitive outlooks for the fatty acid oxidation disorders (faods) industry through 2025-2034 with The Business Research Company’s reliable data and in-depth research
What Are the Key Projections for the CAGR of the Fatty Acid Oxidation Disorders (FAODs) Market Size From 2025 to 2034?
The market size for fatty acid oxidation disorders (FAODs) has witnessed significant expansion in the past few years. It’s projected to escalate from $9.55 billion in 2024 to $10.33 billion in 2025, indicating a Compound Annual Growth Rate (CAGR) of 8.1%. This growth during the historical period can be found connected to heightened awareness, an increase in the occurrence of rare and genetic disorders, a surge in the number of product approvals, enhanced government initiatives, and a growing demand for orphan drugs.
The market size for fatty acid oxidation disorders (FAODs) is anticipated to witness robust growth in the coming years, with an estimated value of $13.99 billion by 2029, marking a compound annual growth rate (CAGR) of 7.9%. The projected growth during this period can be credited to the burgeoning demand for endurable bio-products, the growing trend of personalized medicine, early detection of FAODs, increased allocations for research and development, and greater emphasis on enhancing long-term results. In the forecast period, prominent trends include the incorporation of telehealth services, the application of artificial intelligence in diagnostic procedures and drug discovery, developments in genetic testing, advancements in technology, and a move towards patient-oriented care models.
Download a free sample to assess the report’s scope and structure:
https://www.thebusinessresearchcompany.com/sample.aspx?id=21964&type=smp
What Are the Major Market Drivers Behind the Rising Adoption of Fatty Acid Oxidation Disorders (FAODs) Market?
The escalating preference for gene therapy is set to drive the expansion of the fatty acid oxidation disorders (FAODs) market in the future. This medical approach includes the alteration or substitution of faulty genes to avoid or cure diseases. The surge in gene therapy demand stems from its ability to address genetic disorders, cancer, and rare diseases by targeting their genetic roots, fostering considerable investment and progress in biotechnology. It amends metabolic deficiencies caused by fatty acid oxidation disorders by imparting functioning genes, reviving enzymatic activity, increasing energy production, and forestalling disease complications. For instance, in April 2024, the American Society of Gene & Cell Therapy – a US-based entity for gene and cell therapy, reported a 10% increase in the number of gene therapies in Phase III clinical trials in the fourth quarter, signifying the first growth of this type since the third quarter of 2022. Thus, the rising demand for gene therapy is propelling the advancement of the fatty acid oxidation disorders (FAODs) market.
Which Key Market Segments Comprise the Fatty Acid Oxidation Disorders (FAODs) Market and Drive Its Revenue Growth?
The fatty acid oxidation disorders (FAODs) market covered in this report is segmented –
1) By Type: Long Chain, Short Chain
2) By Drug Type: Levocarnitine, Dextrose, Riboflavin, Other Drug Types
3) By Route of Administration: Oral, Intravenous
4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Drug Stores, Online Stores
5) By End User: Hospitals, Clinics, Pharmaceutical Companies
Subsegments:
1) By Long Chain: Very Long-Chain Acyl-CoA Dehydrogenase Deficiency (VLCAD), Long-Chain 3-Hydroxyacyl-CoA Dehydrogenase Deficiency (LCHAD), Trifunctional Protein Deficiency (TFP), Carnitine Palmitoyltransferase II Deficiency (CPT II)
2) By Short Chain: Medium-Chain Acyl-CoA Dehydrogenase Deficiency (MCAD), Short-Chain Acyl-CoA Dehydrogenase Deficiency (SCAD), Carnitine Uptake Defect (CUD)
Request customized data on this market:
https://www.thebusinessresearchcompany.com/customise?id=21964&type=smp
Which Areas Are Leading Regions in the Fatty Acid Oxidation Disorders (FAODs) Market Expansion Across the Globe?
Asia-Pacific was the largest region in the fatty acid oxidation disorders (FAODs) market in 2024. The regions covered in the fatty acid oxidation disorders (FAODs) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Are the Strategic Trends Steering theFatty Acid Oxidation Disorders (FAODs) Market Direction?
Big industry players in the fatty acid oxidation disorders (FAODs) market are concentrating on the creation of cutting-edge solutions such as peroxisome proliferator-activated receptor delta (PPARd) agonists to enhance metabolic management and increase the effectiveness of FAOD treatments. A PPARd agonist is an agent that triggers the PPARd receptor, a controller of fat metabolism, inflammation, and energy equilibrium, and may offer therapeutic benefits for metabolic disorders and heart conditions. For example, in January 2023, the American clinical-stage pharmaceutical firm, Reneo Pharmaceuticals Inc., gained Fast Track status from the U.S. Food and Drug Administration (FDA) for its experimental medicine, Mavodelpar (REN001), designed to target long-chain 3-hydroxyacyl-CoA dehydrogenase (LCHAD) deficiency, a genetic characteristic linked with long-chain fatty acid oxidation disorder (LC-FAOD). By igniting PPARd, Mavodelpar aims to fortify mitochondrial performance, increase energy metabolism, and mitigate symptoms linked with LC-FAOD.
View the full report here:
How Is the Fatty Acid Oxidation Disorders (FAODs) Market Conceptually Defined?
Fatty acid oxidation disorders (FAODs) are a group of rare genetic metabolic disorders that impair the body’s ability to convert fats into energy due to a deficiency or absence of specific enzymes required for fatty acid breakdown. Fatty acid oxidation disorders lead to an accumulation of fatty acids in the body, which can cause severe energy deficiency, hypoglycemia, muscle weakness, and potential organ damage, particularly during periods of fasting or illness.
Purchase the full report and get a swift delivery:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=21964
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model